🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
8.23
-0.46 (-5.29%)
Nov 18, 2026, 4:00 PM EST - Market closed

Enanta Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Enanta Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $21.83. The average 1-year stock price forecast is 165.25% higher than the current stock price, while the lowest is $19 (+130.86%) and the highest is $32 (+288.82%).

Price Target: $21.83 (+165.25%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$19$21.83$20$32
Change+130.86%+165.25%+143.01%+288.82%

Analyst Ratings

The average analyst rating for Enanta Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy555555
Buy111111
Hold100000
Sell000000
Strong Sell000000
Total766666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$20
BuyReiterates$20+143.01%Nov 17, 2026

Financial Forecast

Revenue This Year
64.09M
from 63.00M
Increased by 1.73%
Revenue Next Year
86.39M
from 64.09M
Increased by 34.79%
EPS This Year
-3.19
from -2.35
EPS Next Year
-2.27
from -3.19
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingSep 30, 2022Sep 30, 2023Sep 30, 2024Sep 30, 2025Sep 30, 2026Sep 30, 2027
Revenue
86.16M79.20M67.64M65.32M63.00M64.09M
Revenue Growth
-11.24%-8.07%-14.61%-3.42%-3.56%1.73%
Gross Profit
86.16M79.20M67.64M65.32M63.00M63.22M
Gross Margin
100.00%100.00%100.00%100.00%100.00%98.65%
Operating Income
-123.84M-137.21M-121.69M-85.35M-62.38M-72.22M
Net Income
-121.76M-133.82M-116.05M-81.89M-68.25M-66.85M
EPS
-----2.35-3.19
Free Cash Flow
------55.00M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High77.0M
Avg64.1M
Low51.2M

Revenue Growth

Revenue Growth202720282029
High
22.2%
Avg
1.7%
Low
-18.8%

EPS Forecast

EPS202720282029
High-3.08
Avg-3.19
Low-3.30

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-